Tissue Flossing in Tennis Elbow Patients

NCT ID: NCT03834077

Last Updated: 2019-02-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-02-20

Study Completion Date

2019-04-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the present intervention is to determine the effectiveness of the application of tissue flossing in patients with tennis elbow

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The application of tissue flossing has been deemed to provide beneficial results in patients with ankle range of motion limitation. Although, tissue flossing is widely extended among athletes due to its effectiveness in pain, function and range of motion, the evidence is limited.

The aim of the present protocol is to determine the effectiveness of tissue flossing in patients with tennis elbow.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Tennis Elbow

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized controlled trial
Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Caregivers Investigators Outcome Assessors
Patients will be allocated to intervention (flossing) or control group (conventional physiotherapy) using a randomized list of allocated numbers generated by a computer program. Opaque envelope will contain the patients allocation while outcome assessors, care provider and principal investigator will be blinded to the allocation process.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Tissue flossing

Conventional physiotherapy consisted in electrotherapy and stretching in addition to tissue flossing.

Group Type EXPERIMENTAL

Tissue flossing

Intervention Type OTHER

Electrotherapy (transcutaneous electrical nerve stimulation) and Ultrasound in addition to tissue flossing.

Placebo comparator

Conventional physiotherapy consisted in electrotherapy and stretching in addition with tissue flossing without tension.

Group Type PLACEBO_COMPARATOR

Placebo comparator

Intervention Type OTHER

Conventional physiotherapy in addition to flossing without tension

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Tissue flossing

Electrotherapy (transcutaneous electrical nerve stimulation) and Ultrasound in addition to tissue flossing.

Intervention Type OTHER

Placebo comparator

Conventional physiotherapy in addition to flossing without tension

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Elbow pain for at least 6 weeks and satisfy the widely accepted diagnostic criteria of lateral epicondylalgia.
* Diagnostic criteria are pain over the lateral humeral epicondyle that is provoked by gripping activities.
* Reduced grip strength and increased sensitivity to manual palpation over the lateral epicondyle.
* Pain with stretching or contraction of the wrist extensor muscles.

Exclusion Criteria

* Upper limb fractures, surgery or concomitant disease.
* Red flags presence.
* Mental disorders.
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Jaén

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

DAVID CRUZ DÍAZ

Vice Dean

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

David Cruz-Diaz, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Jaen

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Jaen

Jaén, , Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

David Cruz-Diaz, PhD

Role: CONTACT

953213408

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Ujaenflossing

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.